Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03567226|
Recruitment Status : Completed
First Posted : June 25, 2018
Last Update Posted : January 15, 2019
|Condition or disease||Intervention/treatment||Phase|
|Glaucoma||Behavioral: WeChat Group Behavioral: Counselling||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||102 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients: A Pilot Study|
|Actual Study Start Date :||June 25, 2018|
|Actual Primary Completion Date :||November 26, 2018|
|Actual Study Completion Date :||November 26, 2018|
Experimental: Intervention Group
The intervention group will be enrolled into a WeChat Group to receive reminders to exercise and health education materials.
Behavioral: WeChat Group
Consenting participants will be randomized to either the intervention or the control arm after successfully wearing an accelerometer for one week. The WeChat Group will be a community forum to share information, encourage each other, and receive communications from the study team. In addition, the study team will disseminate the following information through the group:
Active Comparator: Control Group
Controls will receive a handout telling them to increase walking and that walking may be helpful for the eye at the return visit.
Study participants in the control group will receive a handout telling them to increase walking and will be counseled that walking may be helpful for the eye at the return visit
- Efficacy of using WeChat as an intervention to increase physical activity in Chinese glaucoma patients [ Time Frame: 5 weeks ]
The primary outcome variable will be the number of daily steps taken over the course of one month for each participant. This outcome will be measured by having participants wear the Accelerometer WGT3X-BT, from which we can collect steps data. From this primary outcome measure we will also assess the change in number of steps taken comparing the first week to the following month after the intervention.
Assuming mean enrollment number of steps per day is 9,302.29, we can detect an average increase of 2,500 steps per day with alpha set to 0.05 with 80% power.
- Time spent in moderate to vigorous physical activity [ Time Frame: 5 weeks ]We will also analyze the time spent in moderate to vigorous physical activity.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03567226
|The affiliated eye hospital of Wenzhou Medical University|
|Wenzhou, Zhejiang, China|
|Principal Investigator:||David Friedman, MD, MPH, PhD||Johns Hopkins University|
|Principal Investigator:||Yuanbo Liang, MD, PhD||Clinical & Epidemiological Eye Research Centre, The affiliated eye hospital of Wenzhou Medical University|